Evidence map›Paper›PMID 23675307›Full record

ArticlePLoS genetics2013

Liver x receptors protect from development of prostatic intra-epithelial neoplasia in mice.

Aurélien J C Pommier, Julie Dufour, Georges Alves, Emilie Viennois, Hugues De Boussac, Amalia Trousson, David H Volle, Françoise Caira, Pierre Val, Philippe Arnaud and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Nuclear Receptors and Lipid Sensing.Advances in experimental medicine and biology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. LXRs, SHP, and FXR in Prostate Cancer: Enemies orNuclear receptor signaling · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Cholesterol and breast cancer pathophysiology.Trends in endocrinology and metabolism: TEM · 2014
    Review
  20. A multigenic approach to evaluate genetic variants of PLCE1, LXRs, MMPs, TIMP, and CYP genes in gallbladder cancer predisposition.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Aurélien J C PommierClermont Université, Université Blaise Pascal, Génétique Reproduction et Développement, BP 10448 Clermont-Ferrand, France.
Julie Dufour
Georges Alves
Emilie Viennois
Hugues De Boussac
Amalia Trousson
David H Volle
Françoise Caira
Pierre Val
Philippe Arnaud
Jean-Marc A Lobaccaro
Silvère Baron
Centre de Recherche en Nutrition Humaine d'Auvergne · FRCentre National de la Recherche Scientifique · FRClermont Université · FRGenetique Reproduction and Developpement · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LXR (Liver X Receptors) act as "sensor" proteins that regulate cholesterol uptake, storage, and efflux. LXR signaling is known to influence proliferation of different cell types including human prostatic carcinoma (PCa) cell lines. This study shows that deletion of LXR in mouse fed a high-cholesterol diet recapitulates initial steps of PCa development. Elevation of circulating cholesterol in Lxrαβ-/- double knockout mice results in aberrant cholesterol ester accumulation and prostatic intra-epithelial neoplasia. This phenotype is linked to increased expression of the histone methyl transferase EZH2 (Enhancer of Zeste Homolog 2), which results in the down-regulation of the tumor suppressors Msmb and Nkx3.1 through increased methylation of lysine 27 of histone H3 (H3K27) on their promoter regions. Altogether, our data provide a novel link between LXR, cholesterol homeostasis, and epigenetic control of tumor suppressor gene expression.

Indexed as

AnimalsCarcinomaCholesterolDiet, High-FatDown-RegulationEnhancer of Zeste Homolog 2 ProteinGene Expression Regulation, NeoplasticHistonesHomeodomain ProteinsHumansLiver X ReceptorsMaleMethylationMiceMice, KnockoutNeoplasms, Experimentalbeta-microseminoproteinCholesterolEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHistonesHomeodomain ProteinsLiver X ReceptorsNkx3-1 protein, mouseOrphan Nuclear ReceptorsPolycomb Repressive Complex 2Prostatic Secretory ProteinsTranscription Factors

Identifiers

PMID23675307
PMCPMC3649972
OpenAlexW2044757108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.